Suppr超能文献

探索个人乳腺癌风险评估的实施情况。

Exploring Implementation of Personal Breast Cancer Risk Assessments.

作者信息

Sierra Maria A, Wheeler Jack C W, Devereux Lisa, Trainer Alison H, Keogh Louise

机构信息

Miller School of Medicine, University of Miami, Miami, FL 33136, USA.

Centre for Health Equity, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC 3000, Australia.

出版信息

J Pers Med. 2021 Sep 30;11(10):992. doi: 10.3390/jpm11100992.

Abstract

Personal Breast Cancer (BC) Risk Assessments (PBCRA) have potential to stratify women into clinically-actionable BC risk categories. As this could involve population-wide genomic testing, women's attitudes to PBCRA and views on acceptable implementation platforms must be considered to ensure optimal population participation. We explored these issues with 31 women with different BC risk profiles through semi-structured focus group discussions or interviews. Inductive thematic coding of transcripts was performed. Subsequently, women listed factors that would impact on their decision to participate. Participants' attitudes to PBCRA were positive. Identified themes included that PBCRA acceptance hinges on result actionability. Women value the ability to inform decision-making. Participants reported anxiety, stress, and genetic discrimination as potential barriers. The age at which PBCRA was offered, ease of access, and how results are returned held importance. Most women value the opportunity for PBCRA to inform increased surveillance, while highlighting hesitance to accept reduced surveillance as they find reassurance in regular screening. Women with pathogenic variants value the potential for PBCRA to identify a lower cancer risk and potentially inform delayed prophylactic surgery. This study highlights complexities in adopting advances in BC early detection, especially for current users who value existing processes as a social good.

摘要

个人乳腺癌(BC)风险评估(PBCRA)有潜力将女性分层到临床可采取行动的BC风险类别中。由于这可能涉及全人群的基因检测,必须考虑女性对PBCRA的态度以及对可接受实施平台的看法,以确保最佳的人群参与度。我们通过半结构化焦点小组讨论或访谈,与31名具有不同BC风险特征的女性探讨了这些问题。对访谈记录进行了归纳主题编码。随后,女性列出了会影响她们参与决策的因素。参与者对PBCRA的态度是积极的。确定的主题包括,PBCRA的接受取决于结果的可采取行动性。女性重视为决策提供信息的能力。参与者报告焦虑、压力和基因歧视是潜在障碍。提供PBCRA的年龄、获取的便利性以及结果的反馈方式很重要。大多数女性重视PBCRA为加强监测提供信息的机会,同时强调在接受减少监测方面的犹豫,因为她们在定期筛查中能找到安心感。携带致病变体的女性重视PBCRA识别较低癌症风险并可能为延迟预防性手术提供信息的潜力。这项研究凸显了在采用BC早期检测进展方面的复杂性,特别是对于那些将现有流程视为社会公益的当前使用者而言。

相似文献

1
Exploring Implementation of Personal Breast Cancer Risk Assessments.
J Pers Med. 2021 Sep 30;11(10):992. doi: 10.3390/jpm11100992.
5
"A Natural Progression": Australian Women's Attitudes About an Individualized Breast Screening Model.
Cancer Prev Res (Phila). 2019 Jun;12(6):383-390. doi: 10.1158/1940-6207.CAPR-18-0443. Epub 2019 Apr 19.
7
Women's responses and understanding of polygenic breast cancer risk information.
Fam Cancer. 2020 Oct;19(4):297-306. doi: 10.1007/s10689-020-00185-2.
9
Women's perceptions of personalized risk-based breast cancer screening and prevention: An international focus group study.
Psychooncology. 2019 May;28(5):1056-1062. doi: 10.1002/pon.5051. Epub 2019 Mar 25.

引用本文的文献

2
Cohort Profile: Lifepool.
Int J Epidemiol. 2025 Apr 12;54(3). doi: 10.1093/ije/dyaf044.
4
Polygenic risk scores in the clinic: a systematic review of stakeholders' perspectives, attitudes, and experiences.
Eur J Hum Genet. 2025 Mar;33(3):266-280. doi: 10.1038/s41431-024-01747-z. Epub 2024 Nov 23.
10
Proactive breast cancer risk assessment in primary care: a review based on the principles of screening.
Br J Cancer. 2023 May;128(9):1636-1646. doi: 10.1038/s41416-023-02145-w. Epub 2023 Feb 3.

本文引用的文献

1
Breast cancer polygenic risk scores: a 12-month prospective study of patient reported outcomes and risk management behavior.
Genet Med. 2021 Dec;23(12):2316-2323. doi: 10.1038/s41436-021-01288-6. Epub 2021 Aug 2.
3
CanRisk Tool-A Web Interface for the Prediction of Breast and Ovarian Cancer Risk and the Likelihood of Carrying Genetic Pathogenic Variants.
Cancer Epidemiol Biomarkers Prev. 2021 Mar;30(3):469-473. doi: 10.1158/1055-9965.EPI-20-1319. Epub 2020 Dec 17.
4
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants.
Genet Med. 2020 Oct;22(10):1653-1666. doi: 10.1038/s41436-020-0862-x. Epub 2020 Jul 15.
6
Uptake of polygenic risk information among women at increased risk of breast cancer.
Clin Genet. 2020 Mar;97(3):492-501. doi: 10.1111/cge.13687. Epub 2019 Dec 25.
7
Attitudes towards risk-stratified breast cancer screening among women in England: A cross-sectional survey.
J Med Screen. 2020 Sep;27(3):138-145. doi: 10.1177/0969141319883662. Epub 2019 Nov 8.
8
"A Natural Progression": Australian Women's Attitudes About an Individualized Breast Screening Model.
Cancer Prev Res (Phila). 2019 Jun;12(6):383-390. doi: 10.1158/1940-6207.CAPR-18-0443. Epub 2019 Apr 19.
9
Women's perceptions of personalized risk-based breast cancer screening and prevention: An international focus group study.
Psychooncology. 2019 May;28(5):1056-1062. doi: 10.1002/pon.5051. Epub 2019 Mar 25.
10
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.
Am J Hum Genet. 2019 Jan 3;104(1):21-34. doi: 10.1016/j.ajhg.2018.11.002. Epub 2018 Dec 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验